Cannabinoides
Goethe University Frankfurt
Francfort, AlemaniaPublicaciones en colaboración con investigadores/as de Goethe University Frankfurt (11)
2023
-
Mechanism and evolutionary origins of alanine-tail C-degron recognition by E3 ligases Pirh2 and CRL2-KLHDC10
Cell Reports, Vol. 42, Núm. 9
2022
-
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy
Journal of Medicinal Chemistry, Vol. 65, Núm. 2, pp. 1585-1607
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2016
2013
-
Anandamide deficiency and heightened neuropathic pain in aged mice
Neuropharmacology, Vol. 71, pp. 204-215
2012
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544
2009
2006
-
An overview of Parkinson's disease and the cannabinoid system and possible benefits of cannabinoid-based treatments
Current Medicinal Chemistry, Vol. 13, Núm. 30, pp. 3705-3718
2005
-
Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice
Brain Research, Vol. 1046, Núm. 1-2, pp. 195-206
-
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease
Neurobiology of Disease, Vol. 19, Núm. 1-2, pp. 96-107